A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia
Am J Clin Pathol · 03.03.2026 · 165 (3)
DOI: 10.1093/ajcp/aqag016 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Am J Clin Pathol, online erschienen am 22.03.2026. Verfasst von Giulia Ciarrocca Taranta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Heparin, Thrombocytopenia, Anticoagulants. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instrumentation Laboratory, IgG-specific CLIA.
Abstract (Originalsprache)
Objectives
To evaluate the diagnostic performance of chemiluminescent immunoassay (CLIA), latex immunoturbidimetric assay (LIA), and the combination of CLIA/LIA with respect to the functional heparin-induced platelet aggregation (HIPA) test.
Methods
An observational retrospective study was conducted on 100 patients. All samples were initially tested with CLIA on the ACL TOP AcuStar, and then we performed LIA and CLIA tests concurrently (on the same samples on the ACL TOP 970 CL) and the HIPA test.
Results
The CLIA test was performed on both the AcuStar and the ACL TOP 970 CL, and results were concordant: 68% of patients were negative, and 32% were positive. The HIPA test confirmed a diagnosis in 26 of 32 and identified 6 false-positive patients and 1 false-negative patient. The LIA test was performed on the ACL TOP 970 CL: 64% of patients were negative, and the remaining 36% were positive. The HIPA test confirmed a diagnosis in 24 patients and identified 12 false-positive and 3 false-negative patients. The combination of CLIA and LIA tests allowed us to categorize 27 true-positive, 13 false-positive, 0 false-negative, and 60 true-negative patients.
Conclusions
The combination of CLIA/LIA provides high sensitivity with a progressively greater probability of detecting platelet-activating antibodies with a higher assay reactivity, reaching 100% when both automated assays yield moderate or strong results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
- Atherothrombotic Diseases, "Careggi" University Hospital, Florence, Italy.
ORCID-Profile: Giulia Ciarrocca Taranta, Alessia Bertelli, Andrea Sorrentino, Francesca Cesari, Betti Giusti, Elena Sticchi, Anna Maria Gori, Rossella Marcucci
Förderung
- Instrumentation Laboratory
- IgG-specific CLIA
Zitieren
APA
Ciarrocca Taranta, G., Rogolino, A., Bertelli, A., Sorrentino, A., Di Gioia, M., Cesari, F., Giusti, B., Sticchi, E., Berteotti, M., Gori, A. M., & Marcucci, R. (2026). A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia. Am J Clin Pathol, 165(3). https://doi.org/10.1093/ajcp/aqag016
Vancouver
Ciarrocca Taranta G, Rogolino A, Bertelli A, Sorrentino A, Di Gioia M, Cesari F, et al. A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia. Am J Clin Pathol. 2026;165(3). doi:10.1093/ajcp/aqag016
BibTeX
@article{CiarroccaTaranta2026,
author = {Ciarrocca Taranta, Giulia and Rogolino, Angela and Bertelli, Alessia and Sorrentino, Andrea and Di Gioia, Michela and Cesari, Francesca and Giusti, Betti and Sticchi, Elena and Berteotti, Martina and Gori, Anna Maria and Marcucci, Rossella},
title = {A combination of 2 rapid immunoassays significantly improves diagnostic sensitivity for heparin-induced thrombocytopenia},
journal = {Am J Clin Pathol},
year = {2026},
volume = {165},
number = {3},
doi = {10.1093/ajcp/aqag016}
}
EUVIMED